🇺🇸 FDA
Patent

US 11154608

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

granted A61KA61K2039/5258A61K2039/53

Quick answer

US patent 11154608 (Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5258, A61K2039/53, A61K2039/57, A61K2039/575